{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:46Z","timestamp":1789042906990,"version":"build-2803163510"},"reference-count":52,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Uterine leiomyosarcoma (uLMS) is a rare but highly aggressive mesenchymal malignancy of smooth-muscle origin that represents a significant therapeutic challenge due to its poor prognosis and limited treatment options. Despite advances in molecular characterization, diagnosis remains difficult, and systemic therapies have shown limited success, contributing to a high recurrence rate and poor survival. Recent proteomic investigations have provided new insights into uLMS biology by exploring the global protein expression patterns that define malignant transformation and progression. Using high-resolution mass spectrometry (MS)-based techniques, quantitative proteomics, and integrated multi-omics approaches, researchers have begun to identify dysregulated proteins, signaling pathways, and post-translational modifications (PTMs) linked to tumor metabolism, extracellular matrix (ECM) remodeling, cell-cycle regulation, and chemoresistance. These studies have also uncovered candidate biomarkers that may improve the discrimination of uLMS from benign leiomyoma and have proposed novel therapeutic targets associated with metabolic reprogramming, kinase activation and tumor microenvironment (TME) modulation. This review summarizes recent advancements in uLMS proteomics, discusses their methodological underpinnings, highlights key molecular mechanisms and biomarkers, and explores their translational potential. Finally, we outline current limitations and future directions toward clinical implementation of proteomic findings in precision oncology for uLMS patients.<\/jats:p>","DOI":"10.3390\/cimb48090925","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:38:39Z","timestamp":1789040319000},"page":"925","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Review of Proteomic Studies in Uterine Leiomyosarcoma: Biomarkers, Pathways, and Clinical Potential"],"prefix":"10.3390","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4844-2712","authenticated-orcid":false,"given":"Areti","family":"Kourti","sequence":"first","affiliation":[{"name":"Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-7020","authenticated-orcid":false,"given":"Andigoni","family":"Malousi","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Psatha","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"},{"name":"Laboratory of Medical Biology\u2014Medical Genetics, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"},{"name":"Functional Proteomics and Systems Biology (FunPATh), Center for Interdisciplinary Research and Innovation (CIRI\u2013AUTH), GR-57001 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kalogiannidis","sequence":"additional","affiliation":[{"name":"3rd Department of Obstetrics and Gynecology, Hippokratio General Hospital of Thessaloniki, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-7705","authenticated-orcid":false,"given":"Michalis","family":"Aivaliotis","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"},{"name":"Functional Proteomics and Systems Biology (FunPATh), Center for Interdisciplinary Research and Innovation (CIRI\u2013AUTH), GR-57001 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-0610","authenticated-orcid":false,"given":"Elisavet","family":"Georgiou","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: A review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"Prat","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yang, Q., Madueke-Laveaux, O.S., Cun, H., Wlodarczyk, M., Garcia, N., Carvalho, K.C., and Al-Hendy, A. (2024). Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells, 13.","DOI":"10.3390\/cells13131106"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ke, Y., You, L., Xu, Y., Wu, D., Lin, Q., and Wu, Z. (2022). DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1084192"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijms.93464","article-title":"Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas","volume":"21","author":"Guo","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/s41467-023-39486-2","article-title":"The proteomic landscape of soft tissue sarcomas","volume":"14","author":"Burns","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin. Proteom."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/prca.201400136","article-title":"Recent advances in targeted proteomics for clinical applications","volume":"9","author":"Domon","year":"2015","journal-title":"Proteom. Clin. Appl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Cptac","year":"2016","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","article-title":"Soft Tissue and Uterine Leiomyosarcoma","volume":"36","author":"George","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7018106","DOI":"10.1155\/2016\/7018106","article-title":"Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma","volume":"2016","author":"Miller","year":"2016","journal-title":"Sarcoma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1007\/s43032-025-01969-6","article-title":"Regional Proteomic Characterization of Uterine Leiomyomas: Implications for Molecular Pathways and Tumor Biology","volume":"32","author":"Gani","year":"2025","journal-title":"Reprod. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ygyno.2025.04.573","article-title":"A deep comparative serum proteomic analysis of uterine leiomyosarcoma and benign uterine leiomyoma","volume":"200","author":"Kopelman","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40364-024-00673-y","article-title":"Advancement in Multi-omics approaches for Uterine Sarcoma","volume":"12","author":"Wang","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"O111.016717","DOI":"10.1074\/mcp.O111.016717","article-title":"Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis","volume":"11","author":"Gillet","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104236","DOI":"10.1016\/j.jprot.2021.104236","article-title":"Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry","volume":"241","author":"Milighetti","year":"2021","journal-title":"J. Proteom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","article-title":"Data-independent acquisition-based SWATH\u2014MS for quantitative proteomics: A tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kumar, V., Ray, S., Ghantasala, S., and Srivastava, S. (2020). An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.543997"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12014-020-09283-w","article-title":"Recent advances in mass spectrometry based clinical proteomics: Applications to cancer research","volume":"17","author":"Macklin","year":"2020","journal-title":"Clin. Proteom."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105091","DOI":"10.1016\/j.phrs.2020.105091","article-title":"Investigation of cancer drug resistance mechanisms by phosphoproteomics","volume":"160","author":"Boulos","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"167632","DOI":"10.1016\/j.bbadis.2024.167632","article-title":"Deep multi-omics integration approach reveals new molecular features of uterine leiomyosarcoma","volume":"1871","author":"Falcao","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12014-024-09452-1","article-title":"Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers","volume":"21","author":"Wenk","year":"2024","journal-title":"Clin. Proteom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-022723-113921","article-title":"Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine","volume":"64","author":"Joshi","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/jclinpath-2015-203561","article-title":"TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma","volume":"69","author":"Baiocchi","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2021.09.026","article-title":"Ki67 as a prognostic marker in uterine leiomyosarcoma: A quantitative systematic review","volume":"266","author":"Travaglino","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-22-0100","article-title":"Aberrant Activation of Cell-Cycle\u2013Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma","volume":"28","author":"Yoshida","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Spari\u0107, R., Andji\u0107, M., Babovi\u0107, I., Nejkovi\u0107, L., Mitrovi\u0107, M., \u0160tuli\u0107, J., Pupovac, M., and Tinelli, A. (2022). Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179728"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/pr700792g","article-title":"Targeted glycoproteomic identification of biomarkers for human breast carcinoma","volume":"7","author":"Abbott","year":"2008","journal-title":"J. Proteome Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dugage, M.R., Nassif, E.F., Italiano, A., and Bahleda, R. (2021). Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.775761"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-12-0436","article-title":"Dual targeting of mTOR and Aurora-A kinase for the treatment of uterine leiomyosarcoma","volume":"18","author":"Savannah","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s44276-025-00190-x","article-title":"Transcriptome profiling of uterine leiomyosarcomas identifies a leiomyoma-like expression pattern that indicates better survival","volume":"3","author":"Khamaiseh","year":"2025","journal-title":"BJC Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.21873\/anticanres.13553","article-title":"Circulating protein biomarkers to differentiate uterine sarcomas from leiomyomas","volume":"39","author":"Glorie","year":"2019","journal-title":"Anticancer. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108634","DOI":"10.1016\/j.maturitas.2025.108634","article-title":"Circulating biomarkers for the preoperative diagnosis of uterine sarcoma: A systematic review and meta-analysis","volume":"199","author":"Taliento","year":"2025","journal-title":"Maturitas"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Casey, A., Allsopp, R., Shaw, J., Cowley, C., Stannard, E., Griffin, Y., Das, I., Wadsley, M., Darko, N., and Moss, E.L. (2026). Development of a blood test for uterine sarcoma\u2014Diagnosis and monitoring (DOORS-D and DOORS-M) studies. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0339336"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.fertnstert.2021.06.023","article-title":"Extracellular matrix remodeling and inflammatory pathway in human endometrium: Insights from uterine leiomyomas","volume":"116","author":"Governini","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e202400279","DOI":"10.1002\/pmic.202400279","article-title":"Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney Disease","volume":"25","author":"Mina","year":"2025","journal-title":"Proteomics"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Petra, E., Siwy, J., Vlahou, A., and Jankowski, J. (2022). Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS ONE, 17, Correction in PLoS ONE\u00a02024, 19, e0305767.","DOI":"10.1371\/journal.pone.0305767"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1021\/acs.jproteome.0c00055","article-title":"Enrichment of Collagen Fragments Using Dimeric Collagen Hybridizing Peptide for Urinary Collagenomics","volume":"19","author":"Kessler","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1655","DOI":"10.1002\/ctm2.1655","article-title":"PI3K\/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6 high uterine leiomyosarcoma to PD-1 blockade","volume":"14","author":"Annibali","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7150\/jca.81623","article-title":"Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2\/VEGFA Expression and Lipid Metabolism Pathway","volume":"14","author":"Ding","year":"2023","journal-title":"J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Yoshida, K., Yokoi, A., Yamamoto, T., Hayashi, Y., Nakayama, J., Yokoi, T., Yoshida, H., Kato, T., Kajiyama, H., and Yamamoto, Y. (2022). Integrative transcriptomics analysis for uterine leiomyosarcoma identifies aberrant activation of cell cycle-dependent kinases and their potential therapeutic significance. medRxiv.","DOI":"10.1101\/2022.01.06.22268775"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"167103","DOI":"10.1016\/j.bbadis.2024.167103","article-title":"Uterine leiomyosarcoma cell-derived extracellular vesicles induce the formation of cancer-associated fibroblasts","volume":"1870","author":"Nagao","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/ol.2021.12630","article-title":"Altered glycolysis results in drug-resistant in clinical tumor therapy (Review)","volume":"21","author":"Peng","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.18632\/oncotarget.1658","article-title":"Anti-oxidative stress response genes: Bioinformatic analysis of their expression and relevance in multiple cancers","volume":"4","author":"Rotblat","year":"2013","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/D0MO00072H","article-title":"Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology","volume":"17","author":"Krasny","year":"2021","journal-title":"Mol. Omics"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/925\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:03:42Z","timestamp":1789041822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cimb48090925"],"URL":"https:\/\/doi.org\/10.3390\/cimb48090925","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}